1. Home
  2. GBIO vs STRT Comparison

GBIO vs STRT Comparison

Compare GBIO & STRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • STRT
  • Stock Information
  • Founded
  • GBIO 2016
  • STRT 1908
  • Country
  • GBIO United States
  • STRT United States
  • Employees
  • GBIO N/A
  • STRT N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • STRT Auto Parts:O.E.M.
  • Sector
  • GBIO Health Care
  • STRT Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • STRT Nasdaq
  • Market Cap
  • GBIO 165.5M
  • STRT 172.2M
  • IPO Year
  • GBIO 2020
  • STRT 1995
  • Fundamental
  • Price
  • GBIO $1.10
  • STRT $41.25
  • Analyst Decision
  • GBIO Strong Buy
  • STRT
  • Analyst Count
  • GBIO 2
  • STRT 0
  • Target Price
  • GBIO $7.50
  • STRT N/A
  • AVG Volume (30 Days)
  • GBIO 425.8K
  • STRT 19.4K
  • Earning Date
  • GBIO 11-06-2024
  • STRT 02-06-2025
  • Dividend Yield
  • GBIO N/A
  • STRT N/A
  • EPS Growth
  • GBIO N/A
  • STRT N/A
  • EPS
  • GBIO N/A
  • STRT 3.94
  • Revenue
  • GBIO $18,582,000.00
  • STRT $541,412,000.00
  • Revenue This Year
  • GBIO $212.74
  • STRT $1.94
  • Revenue Next Year
  • GBIO N/A
  • STRT $4.24
  • P/E Ratio
  • GBIO N/A
  • STRT $10.58
  • Revenue Growth
  • GBIO 514.08
  • STRT 6.58
  • 52 Week Low
  • GBIO $0.75
  • STRT $21.05
  • 52 Week High
  • GBIO $4.65
  • STRT $44.27
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 34.72
  • STRT 53.20
  • Support Level
  • GBIO $1.03
  • STRT $39.75
  • Resistance Level
  • GBIO $1.12
  • STRT $42.28
  • Average True Range (ATR)
  • GBIO 0.13
  • STRT 1.63
  • MACD
  • GBIO 0.02
  • STRT -0.23
  • Stochastic Oscillator
  • GBIO 55.56
  • STRT 52.43

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

Share on Social Networks: